Cancelling your registration will remove your access to the event. If you proceed, you will no longer be able to participate or access event-related materials.
Deleting your account will remove your access to the event.
Dr. Barzilai is a longevity physician and Lecturer at Harvard Medical School, and a founding faculty member and Trustee of the Geneva College of Longevity Science, where he helps shape the emerging field of longevity medicine. Holding an MD, PhD, and MBA, and board-certified as a Diplomate of the American Board of Lifestyle Medicine, he integrates clinical expertise with biomarker analytics, precision protocols, and performance-focused interventions across cardiovascular, metabolic, cognitive, musculoskeletal, and preventive health. A scientific and strategic advisor and frequent keynote speaker in the longevity and health-tech sectors, he is known for translating complex scientific advances into clear, actionable strategies. He is the CEO of Barzilai Longevity Consulting and the physician behind Agingdoc.com, delivering personalized longevity guidance for individuals, executives, and organizations seeking to extend and optimize healthspan.
Mr. Ray Bingham General Partner, Health2047 Capital Partners and Board Director at Health2047 Inc. which was founded by the American Medical Association (the ‘AMA’), together with United Health Group a diversified healthcare company, which serves over 148 million customers in the United States.
Ray also serves as Co-Founding Partner of Canyon Bridge Capital Partners Inc. Ray’s distinguished career spans over 35 years of investing in, and building businesses focused on technology, AI, chemical engineering and hospitality real estate development.
Over the last three decades Michel Bouquier, has built a matchless reputation for promoting luxury lifestyle around the world. Before launching, in January 2024, his own company {M}, a private social club based on Art, Philanthropy and Health, Michel was a Senior Advisor to the Monaco Government Finance and Economy Department responsible for promoting the Principality’s attractiveness. He headed “Monaco Private Label”, a tailor-made initiative designed for high profile international investors. He graduated from the Strasbourg School of Hotel Management and Tourism and obtained a Master degree and a postgraduate degree in Human Sciences at Lyon II University. Michel is honoured with the French National Order of Merit and the Principality of Monaco’s Saint Charles Order.
At the beginning of his career, Kevin worked for Swiss Re in the large corporate direct insurance division called Swiss Re Corporate Solutions. A personal incident of medical malpractice has made him find his purpose in health management. Today, Kevin is the CEO at SIP Medical Family Office. For over 25 years, individuals, families, and companies have been relying on SIP’s expertise to protect their health around the world. Founded as an International Private Medical Insurance advisor, SIP has developed into what is today known as a Medical Family Office. Combining the expertise from private medical insurance with a holistic approach towards proactively planning one’s health, it has been SIP’s mission to protect people’s health since 1997.
While International Private Medical Insurance remains an important focus, SIP has developed a Medical Concierge proposition to plan people’s health strategically and ensure better outcomes in acute situations. This ranges from Privileged Healthcare to Preventive Medicine, Longevity, Medical Records Management, and more.
Mr. Alex Charlton, Chairman and CEO of the Carlyle Global Partners family-wealth holder group, the by-invitation community, built upon trust and connected through common interests for the advancement of knowledge and innovation through selective investing and philanthropy.
The Carlyle family wealth-holder group includes over 250 accomplished families, (about 900 individual family members) from around the world, with combined investible assets approaching $180 billion.
Joe has been working in the health insurance and assistance industry for over twenty five years and is passionate about helping clients find the very best solutions for their global healthcare needs. He is based in Germany and looks after broker partnerships and distribution for IMG in Northern and Eastern Europe.
Dr. Lisa Corsa is the founder of the PTVIP Medical Concierge Crisis Program, a one-of-a-kind, private membership-only concierge rehabilitation service. This exclusive program is unparalleled by any other service or company in the world. Dr. Corsa and her elite medical team are equipped to handle any medical emergency— whether in your home, aboard your private yacht, or while you're on vacation.
A recognized expert in physical therapy medicine, manual osteopathy, and certified athletic training, Dr. Corsa is often referred to as the Navy SEAL of rehabilitation medicine. She has successfully treated thousands of patients from across the globe, many of whom fly into her state-of-the-art facility in Boca Raton, FL for exclusive, one-on-one care.
Dr. Corsa will not stop until she identifies and treats the root cause of each patient’s condition, dedicating her expertise and persistence to delivering lasting, life changing results.
Nathan Ikon Crumpton is a two-time, two-sport Olympian. One of fewer than 75 Olympians in history to compete individually in both the Summer & Winter Olympics, he achieved a highest world rank of 8th in skeleton racing and finished 3x as the top American at global championships. Competing in athletics for American Samoa, he holds two national records and was the 3x national champion in the 100m. He is a cum laude graduate of Princeton University and a cosmopolitan entrepreneur. Beyond sports, Crumpton is a multi-agency-represented model, a gallery-represented photographer, and the author of the non-fiction novel Alpha Status. Having lived in seven countries on four continents, he brings a uniquely global perspective to his diverse professional and athletic pursuits.
Dr. Wolfgang Daum, CEO of Carlyle Global Advisors and Carlyle One Health, is a serial entrepreneur and investor, working with accomplished family wealth-holders around the world.
On behalf of Carlyle Advisors family wealth-holder clients, Dr. Daum specializes in commercializing innovative technology and securing investment participation by leading institutional investors and strategic corporate investors. Dr. Daum has special expertise in the wellness and healthcare sectors.
Ms. Francesca Dego is an accomplished young Italian American violinist celebrated for her compelling interpretations and flawless technique.
In 2026, Francesca will commence a residency at Wigmore Hall, one of the world’s great concert halls. Over the next few seasons Ms. Francesca Dego will also be performing Concertos alongside some of the most admired international orchestras.
In 2023, Francesca made her recording debut with the London Symphony Orchestra as the first artist to be featured on Apple Classical in A New Dawn featuring Bologne’s Chevalier de St Georges Concerto No. 2 alongside Jonathon Heyward. She regularly collaborates with esteemed conductors.
Dr Sabine Donnai is an international authority in proactive health management and a highly regarded Harley Street general physician. As the founder and chief executive of Viavi, she has led the development of advanced health strategy services for healthy longevity and performance, combining cutting edge science and hyper-personalisation. Viavi’s clients include senior figures globally from business, finance, the professions and entrepreneurs. Sabine appears frequently in the media and on podcasts, as well as delivering thought-leadership talks. Most recently she appeared on BBC’s Panorama discussing the risks associated with PFAS, forever chemicals . Sabine sits on the international expert advisory board on the prevention of Alzheimers. Her first book on brain health will be published in early 2027.
Doug Given, MD is a Member of Carlyle’s family wealth-holder group, and Managing Partner, of the investment firm Health2047 Capital, which was founded by the American Medical Association (the ‘AMA’), together with United Health Group a diversified healthcare company, which serves over 148 million customers in the United States.
Doug previously served as General Partner of the global life science investment firm, Bay City Capital, where for over 20-years he served as an investment Partner and General Partner, participating in five sequential life sciences general funds and two sector-specific funds.
Alex Gray is an internationally renowned live MC and television host, recognised for her versatility across a wide range of sectors, including sport, health, finance, and lifestyle. Her presenting work has seen her host for prestigious names such as the BBC, Henley & Partners, QVC, and Red Bull.
Alongside her broadcasting and live hosting career, Alex has become a respected voice within the autoimmune community, speaking at events including the Allergen and Free From Show and the Genesis Health Conference. After appearing as a contestant on the BBC hit show The Traitors, she has also developed a series of talks on the psychology of lying, informed by both her first-hand experience on the programme and her academic training in psychology.
Alex grew up in Cambridge and graduated from University College London with a first-class BSc in Psychology.
Mark Jackson is the Founder and CEO of Vitaspan, a health-data infrastructure platform designed to unify fragmented medical records into a structured longitudinal health record. Vitaspan enables clinics, physicians, and patients to access a complete health picture while supporting AI-driven risk prediction for preventative medicine. Mark spent more than two decades in global technology leadership, including senior roles at Thomson Reuters, where he built large-scale strategic partnerships with firms such as Microsoft, IBM, and Oracle. His work with Vitaspan focuses on solving one of healthcare’s most persistent problems: the fragmentation of medical data across countries, providers, and systems. This challenge is particularly acute for internationally mobile families.
Mark’s mission is to give individuals true ownership of their health information while enabling physicians to deliver more proactive and personalised care.
Chantal joined SIP Medical Family Office as a Client Advisor in April 2024. As an independent intermediary, specialising in Private Clients and SMEs, she has over 11 years’ experience in the industry looking at both International Private Medical Insurance as well as domestic UK PMI.
E. Marco Liardo is the Head and Managing Director for Switzerland and the Americas at Charles Monat Associates. In this role, he leads the development and delivery of highly personalized liquidity planning solutions, working closely with sophisticated private clients to help them preserve, protect, and grow their wealth across generations.
Marco also mentors his sales consultant teams in Switzerland and the Americas, fostering a high performance culture rooted in integrity and client focus. He manages a continuously growing network of trusted referral partners, cultivating long-term relationships. Marco is an appointed member of the Global Advisory Council, which reports directly to the Group Executive Committee. In this capacity, he contributes to shaping the firm’s strategic response to the evolving landscape of global wealth management.
With 25 years of experience advising UHNW/HNW clients, Marco brings a deep understanding of both the technical aspects of insurance and the nuances of private banking. Prior to joining Charles Monat Associates, he successfully built and led the Swiss hub of another international life insurance brokerage firm. He also held a senior role in Private Banking Life Insurance, at a global Swiss private bank, where he led the launch and implementation of the bank’s life insurance referral platform in Switzerland. Earlier in his career, Marco served as Head of Financial Analysis and Senior M&A Manager at a leading global insurance group.
Marco’s combined expertise in insurance structuring and private banking uniquely positions him to deliver exceptional succession planning advice to clients and banking partners alike.
He holds a Master’s degree in Finance and Capital Markets from the University of Basel, Switzerland.
With over 20 years’ experience across international insurance — spanning health, life and pensions — Adam is a CERTIFIED FINANCIAL PLANNER™ and member of the European leadership team at Bupa Global.
Responsible for driving growth and distribution partnerships across European markets, Adam oversees the delivery of market-leading healthcare solutions with a strong focus on both corporate and high net worth client segments.
Todd McAllister, PhD, is widely regarded as one of the original architects of Longevity Medicine and a leading visionary in the transformation of modern healthcare. A scientist, entrepreneur, and systems thinker, his work has helped shift medicine from a reactive, disease-centered model to a proactive, data-driven discipline focused on extending healthspan, performance, and functional longevity. Over the past 25 years, Dr. McAllister has founded, scaled, and advised companies at the forefront of preventive and regenerative healthcare. He was the co-founder and CEO of Fountain Life, alongside Tony Robbins and Peter Diamandis—one of the first companies globally to focus explicitly on proactive, prevention-based care rather than episodic disease treatment. At Fountain Life, Dr. McAllister designed and operationalized what has become the foundational clinical framework for longevity medicine, organizing care around three core pillars: Precision Diagnostics, Performance Optimization, and Advanced Therapeutics. This integrated model established the clinical focus on healthspan over lifespan and continues to define the approach used by longevity clinics worldwide. Following Fountain Life, Dr. McAllister partnered with ProMedica Health System, the 14th largest healthcare system in the United States, to build and operate the Icaria Longevity Center. This initiative embedded proactive longevity care within a traditional primary care environment, demonstrating how advanced prevention models could scale within large healthcare systems and helping bring longevity medicine closer to the mainstream. Dr. McAllister also brings exceptional scientific credibility to the field. His pioneering work in cell-based therapies was recognized by Scientific American as one of the Top 50 achievements in science, business, and policy, and he is a two-time finalist for the NIH Pioneer Award. His research has been widely published in top-tier journals, including The New England Journal of Medicine, Lancet, Nature Medicine, and Science, contributing to the clinical understanding of regenerative therapies, translational medicine, and the biology of aging. Most recently Dr. McAllister co-founded Skai Health, a network of concierge primary care clinics in the UK and Middle East. As Skai’s Founding Scientist, he continues his mission to translate complex biological data into clear, actionable care—turning early insight into lasting health.
Dr. Roxana Mittler-Matica is a board-certified neurosurgeon and engineer, currently Chief Medical Officer of FormMed HealthCare GmbH - a leading German provider of premium micronutrient formulations drawing on more than 30 years of experience in orthomolecular medicine – she leads medical affairs and innovation in preventive health.
With clinical experience across multiple European healthcare systems and a background in digital care pathway development, she operates at the intersection of neuroscience, precision micronutrient medicine, and preventive health strategy.
Her work focuses on translating systems biology into actionable prevention — advancing evidence-based micronutrient concepts, peri-operative optimization programs, and AI-supported risk models that aim to shift healthcare from reactive disease management toward proactive longevity design.
Dr. Mittler-Matica regularly advises on medical innovation and European research initiatives and advocates for health as strategic infrastructure in modern societies.
Head Wealth Planning Key Clients & Family Office Services, Bank Julius Baer & Co. Ltd.
Maria is a senior professional advising private clients and Single Family Offices across various regions in complex multi-jurisdictional wealth planning matters. She joined Julius Baer in 2011, following her experience in wealth planning, succession and tax advisory at law firms, fiduciary and tax consultancy firms.
Passionate about family governance and education, Maria frequently participates as lecturer in the area of international wealth planning & family office wealth management at different educational programs. She is an attorney-at-law, holds a Master's in International Taxation from the Vienna University of Economics and Business, is certified as a Trust & Estate Practitioner (TEP), and has more than 20 years of professional experience.
Edouard specializes in the purchase, sale of trophy assets, with a strong expertise in, construction, financing, chartering and registration of large yachts and vessels. He advises numerous stakeholders in the maritime industry and in the field of exceptional assets, both in France and internationally, and has significant experience in international business law and contract law.
Currently Vice-President of the Monaco Yachting Cluster, he is convinced that certain exceptional assets represent genuine vehicles for transmission.
Edouard has a particular interest in the concept of Family Longevity. His presentation will explore how the acquisition and structuring of assets — such as exceptional properties, art collections… — can become true “legacy assets”, reflect a lifestyle and foster harmonious transmission between generations.
Following a career in communications, Oliver decided to turn his talents to something more meaningful and has subsequently (and successfully) been working in the field of addiction treatment. NEOVIVA is the result of a long journey that began with his personal recovery from addiction some 30+ years ago. “It is my sincere wish that everyone who is suffering from addiction can find help,” Oliver says, “and at NEOVIVA, we have chosen our dedicated staff for their experience, empathy, and personal engagement for the well-being of our clients.”
Certified not only as a Postgraduate in Addiction Psychology & Counselling and a master’s degree in Addiction Studies by King’s College London but also “certified as a little dreamy and a bit impatient” by us, his zest for action is undeniable. True to his goal to implement his visions today rather than tomorrow, he and Fenina have joined forces to found NEOVIVA. When he is not involved in something NEOVIVA-related, he likely is trying to birdie the next hole, or spending time with his three donkeys.
Dr. Damien Ng is a Senior Thematic Research Analyst at Julius Baer, specialising in demographics, longevity, and well-being. He holds a PhD from Durham University and brings global experience from roles at Goldman Sachs and Reuters. A published author and sought-after speaker, Ng frequently presents at Julius Baer, universities, and external events, sharing insights at the intersection of finance and healthcare.
Philip Nitschke is the Founder of Exit International, an international non profit organisation which advocates for the fundamental human right of every rational adult over a certain age to make their own end of life decisions.
In 1997, Philip became the first doctor in the world to help four terminally ill patients to die under Australia’s short-lived Rights of the Terminally Ill Act.
For the past 2 decades, Philip has been the lead author of the Peaceful Pill Handbook, which is the leading guide on practical end of life choices.
He is also the inventor of a range of end of life devices such as the Deliverance Machine (British Science Museum) and the 3D-printed Sarco device which was first used by a serious ill American woman in Switzerland in September 2024.
Philip holds a PhD in applied physics from Flinders University in Adelaide and is a graduate of Sydney Medical School.
Corinne is a tax expert with particular know-how on a range of international tax matters affecting private clients in respect of their investments, business projects and estate planning.
She has acquired extensive expertise in advising on pre-immigration tax planning for new Monaco residents, notably on the reorganization of foreign holding structures owning Monaco or French real estate assets, as well as succession planning during Monaco residence. Corinne further has a strong practice of cross-border transactional tax law. She advises successful entrepreneurs on group reorganizations, including the negotiation of tax rulings before the tax authorities.
Committed to the challenges of Family Longevity, Corinne will focus on succession planning issues, the pitfalls to avoid and the management of conflicts of laws in order to secure the transmission of family wealth.
Amelie Sarrado serves as Director, Head of Private Office at Christie’s, where she leads the firm’s work on top global collections. She works hand in hand with family offices and professional advisors to advise UHNW collectors on building and strategically managing their art collection.
Recent market shifts have meant an increased focus on art, both as an asset within a diversified portfolio and as a cornerstone of long-term legacy planning for established collection. In this evolving landscape, changes in collecting tastes and the need for agile navigation of complex family dynamics can have a defining impact on the longevity and integrity of a collection’s legacy. Active, thoughtful management alongside trusted long-term relationships are essential to guiding collectors through this journey successfully.
Amelie also sits on the Courtauld Advisory Board, where she contributes to a project focused on next-generation digital innovation. Previously, she served as Chief of Staff to Christie’s CEO, Guillaume Cerutti, and led the Asian Art departments across Christie’s Europe.
Xavier is recognized as an international expert on Family Governance matters. Author of several articles on the subject, he regularly speaks at international conferences and forums.
He is an expert in succession and estate planning, as well as asset protection mechanisms, and he serves as Director, Trustee or Protector of several family or private groups, based in Europe, US and Asia.
Through his involvement in the setting up and management of sophisticated Private Client structures he has acquired a unique hands-on experience of such organizations.
Deeply committed to the concept of Family Longevity, Xavier will address the way in which an appropriate organization can ensure proper longevity of a family and the sustainable transmission of its assets, by combining sound governance, protection and an intergenerational vision.
Mr. Ian Sosso, Carlyle Member and founder of Monte Carlo Capital (MCC). Before launching MCC, Ian worked across Paris, London, Tokyo, Singapore, and Hong Kong at some of the world’s biggest investment banks. Ian was the regional Managing Director and Head of Capital Markets in Asia for Commerzbank.
Ian is a winner of the 2019 “Best European Angel Investor” award and serves on the boards of EBAN—the Brussels-based pan-European angel organization representing the European angel community—and the Monaco Venture Capital Association.
Physician and public health professional at IRCCS San Raffaele Hospital in Milan, engaged in developing innovative models of prevention and personalized medicine. He leads multidisciplinary units and strategic projects, with a focus on organizational efficiency and patient value. His work centers on integrating technology, clinical practice, and healthcare management.